#LLY
-

Eli Lilly Stock Reclaims $1,200 as Mounjaro and Zepbound Power Growth
Eli Lilly shares climbed back above $1,200 as investors responded to blockbuster tirzepatide sales, fresh pipeline expansion, and rising expectations…
-

Eli Lilly Stock Rises After 55.5% Revenue Surge and $82B-$85B Outlook
Eli Lilly stock climbed near $1,011 after first-quarter 2026 revenue jumped 55.54% to $19.80 billion and adjusted momentum across obesity,…